CD8+-enriched short-term cultured anti-tumor autologous lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD8+-enriched short-term cultured anti-tumor autologous lymphocytes, covering 2013-06-03 to 2013-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M... [Phase 2]